GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Shanghai Shen Lian Biomedical Corp (SHSE:688098) » Definitions » 5-Year EBITDA Growth Rate

Shanghai Shen Lian Biomedical (SHSE:688098) 5-Year EBITDA Growth Rate : -2.90% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Shanghai Shen Lian Biomedical 5-Year EBITDA Growth Rate?

Shanghai Shen Lian Biomedical's EBITDA per Share for the three months ended in Mar. 2024 was ¥-0.01.

During the past 12 months, Shanghai Shen Lian Biomedical's average EBITDA Per Share Growth Rate was -81.80% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -12.10% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -2.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 11 years, the highest 3-Year average EBITDA Per Share Growth Rate of Shanghai Shen Lian Biomedical was 5.50% per year. The lowest was -32.60% per year. And the median was -2.65% per year.


Competitive Comparison of Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate falls into.



Shanghai Shen Lian Biomedical 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


Shanghai Shen Lian Biomedical  (SHSE:688098) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.


Shanghai Shen Lian Biomedical 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Shanghai Shen Lian Biomedical's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Shanghai Shen Lian Biomedical (SHSE:688098) Business Description

Traded in Other Exchanges
N/A
Address
No. 48, Jiangchuan East Road, Minhang District, Shanghai, CHN, 200241
Shanghai Shen Lian Biomedical Corp is engaged in the development, production and sales of veterinary biological products.
Executives
Ma Gui Jun Core technical personnel
Gao Yan Chun senior management

Shanghai Shen Lian Biomedical (SHSE:688098) Headlines

No Headlines